Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sutro Biopharma, Inc. STRO

Set alert

Price alert · STRO

All alert types
9.75 USD +0.64 +7.03%

As of Nov 3, 11:32 AM ET

Bid
9.61 × 2
Ask
9.78 × 2
9.03 Day range 9.84
7.15 52-week range 43.85
YTD
-15.73%
1 year
-11.36%
Open
9.20
Prev close
9.11
Mkt cap
162.00M
Vol
35.44K
Avg vol
312.81K
EPS
-17.28
P/E
0.00
Div yield
0.00%
More statistics
Low
9.03
High
9.84
Forward P/E
-0.63
Beta
0.00
Short ratio
2.47
Inst. own
77.14%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
3.12
200-d avg
3.73
1y target
11.50

1Y chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Dec 3, 2025Split: 1 for 10
Signals (48)
NameDateAgo
MACD: Buy SignalNov 2, 20261 day ago
RSI: OversoldOct 21, 20261 week ago
MACD: Sell SignalOct 13, 20263 weeks ago
RSI: OversoldOct 9, 20263 weeks ago
RSI: OversoldOct 2, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
RSI: OversoldSep 23, 20261 month ago
RSI: OversoldSep 10, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
MACD: Buy SignalAug 26, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Sell SignalAug 13, 20262 months ago
MACD: Buy SignalJul 31, 20263 months ago
MACD: Sell SignalJul 13, 20263 months ago
SMA: BullishJul 7, 20263 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 15, 20264 months ago
SMA: BearishMay 22, 20265 months ago

Newest 20 of 48.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 11.50 +17.9% upside
Target (low)
4.00
Target (mean)
11.50
Target (high)
20.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy7
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 11
  • 1 month ago 11
  • 2 months ago 11
  • 3 months ago 11

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

STRO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.955-1.13 – -0.780.498-291.8%12.18M-89.3%2
Next quarter-0.92-0.92 – -0.92-0.89-3.4%9.00M-30.8%1
Current year-3.07-3.22 – -2.92-1.73-77.4%59.20M-61.5%2
Next year-3.42-3.90 – -2.93-3.07-11.2%49.20M-16.9%2

Upgrades and downgrades

The latest rating changes

STRO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 11, 2024Wells FargoMaintainedEqual-WeightEqual-Weight
Dec 11, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Nov 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 11, 2024Piper SandlerReiteratedOverweightOverweight
Oct 11, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 16, 2024Truist SecuritiesMaintainedBuyBuy
Aug 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2024OppenheimerMaintainedOutperformOutperform
May 14, 2024WedbushReiteratedOutperformOutperform
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 8, 2024B of A SecuritiesInitiated—Buy
Apr 3, 2024Piper SandlerReiteratedOverweightOverweight
Apr 3, 2024OppenheimerMaintainedOutperformOutperform
Apr 3, 2024Truist SecuritiesMaintainedBuyBuy
Apr 3, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Mar 28, 2024OppenheimerMaintainedOutperformOutperform
Mar 27, 2024OppenheimerMaintainedOutperformOutperform
Mar 26, 2024WedbushMaintainedOutperformOutperform
Mar 26, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Mar 26, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 15, 2023Piper SandlerMaintainedOverweightOverweight
Nov 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 9, 2023Deutsche BankInitiated—Buy
Oct 23, 2023WedbushReiteratedOutperformOutperform
Oct 6, 2023OppenheimerInitiated—Outperform
Sep 6, 2023Truist SecuritiesReiteratedBuyBuy
Aug 14, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 11, 2023HC Wainwright & Co.ReiteratedBuyBuy